Form 4 for MGNX MACROGENICS INC
Accepted 2021-09-20 00:00:00 ET · period of report 2021-09-16 · accession 0000899243-21-036543 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2021-09-20 | 2021-09-16+ | MGNX | BB BIOTECH AG | 10% | P - Purchase | $20.60 | +600.0K | 6.88M | +10% | +$12.36M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-09-16 | P | A | 400,000 | $20.94 | 6,675,564 | D | — | — | |
| 2 | Common | Common Stock | 2021-09-17 | P | A | 200,000 | $19.93 | 6,875,564 | D | — | — |